Jaime Garay Lehmann
About Jaime Garay Lehmann
Jaime Garay Lehmann serves as the Head of Manufacturing at Organogenesis, where he focuses on enhancing process reliability and collaboration with R&D. He has extensive experience in the pharmaceutical industry, having held leadership roles at companies such as Novartis, Pfizer, and GlaxoSmithKline over a career spanning more than two decades.
Current Role at Organogenesis
Jaime Garay Lehmann has served as the Head of Manufacturing at Organogenesis since 2019. In this role, he focuses on enhancing process reliability and fostering collaboration with Research and Development (R&D) for new product introductions. He is responsible for developing the organization and infrastructure needed to support accelerated growth and improve gross margins.
Previous Experience in Manufacturing Leadership
Prior to joining Organogenesis, Jaime held several significant positions in the pharmaceutical and consumer health sectors. He was the Global Head of Manufacturing, Science & Technology at Novartis Consumer Health from 2013 to 2015. He also served as the Global Head of Technical (Consumer Health) at GlaxoSmithKline Consumer Healthcare from 2015 to 2019, and as SVP of Global Manufacturing Operations at Mylan Pharmaceuticals from 2011 to 2012.
Career Progression at Pfizer
Jaime Garay Lehmann worked at Pfizer in various capacities from 2004 to 2010. His roles included Site Managing Director in Guayama, Puerto Rico, and VP positions focusing on Network Strategy and Applied Technology. His tenure at Pfizer allowed him to gain extensive experience in manufacturing operations and strategy.
Educational Background
Jaime studied Biochemical Engineering and earned a Bachelor of Science degree from Instituto Tecnológico y de Estudios Superiores de Monterrey. He furthered his education at Cranfield School of Management, where he completed the Wisdom Programme and received a Diploma in 2001.
Expertise in Manufacturing Operations
Jaime has extensive experience leading manufacturing operations across diverse technology platforms, including oral solid doses, injectables, liquids, creams, ointments, and medical devices. He has also led major mergers and acquisitions integration and cGMP turnaround projects, showcasing his capability in managing complex manufacturing environments.